SCHEMBL30008510

SCHEMBL30008510

COC(=O)c1cccc(/C(N)=N/O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ GRIN2D O15399 1/20 0.51
▸ GRIN3B O60391 1/20 0.51
▸ GRIN1 Q05586 1/20 0.51
▸ GRIN2A Q12879 1/20 0.51
▸ GRIN2B Q13224 1/20 0.51
▸ GRIN2C Q14957 1/20 0.51
▸ GRIN3A Q8TCU5 1/20 0.51
▸ TSHR P16473 1/20 0.50
▸ CYP4F2 P78329 2/20 0.49
▸ CYP4A11 Q02928 2/20 0.49
▸ PRSS1 P07477 1/20 0.48
▸ ACR P10323 1/20 0.48
▸ RAB9A P51151 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ CA12 O43570 2/20 0.47
▸ CA1 P00915 2/20 0.47
▸ CA2 P00918 2/20 0.47
▸ CA9 Q16790 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL66472 1.00 LOXL2 (0.54) LOXL2ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL2773914 1.00 LOXL2 (0.54) LOXL2ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL30506553 1.00 LOXL2 (0.54) LOXL2ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL2773919 1.00 LOXL2 (0.54) LOXL2ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL15134086 0.83 TSHR (0.52) LOXL2ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL34953 0.83 TSHR (0.70) LOXL2ALDH1A1TSHRCYP4F2CYP4A11
SCHEMBL6596210 0.82 CYP4F2 (0.51) ALDH1A1TSHRCYP4F2CYP4A11RAB9A
SCHEMBL6596214 0.82 CYP4F2 (0.51) ALDH1A1TSHRCYP4F2CYP4A11RAB9A
SCHEMBL2775628 0.82 CA1 (0.55) LOXL2ALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL13617864 0.82 CA1 (0.55) LOXL2ALDH1A1GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059469-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS AKT INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 — — WO disclosed
EP-3704113-B1 BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS BRISTOL MYERS SQUIBB CO (US) 2023-10-11 — — EP disclosed
EP-3704106-B1 ALKENE COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS BRISTOL MYERS SQUIBB CO (US) 2023-04-12 — — EP disclosed
EP-3377476-B1 HYDROGEN ISOTOPE-ENRICHED ANALOGUES OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS, COMPOSITIONS AND USES THEREOF PTC THERAPEUTICS INC (US) 2022-10-26 — — EP disclosed
Send feedback